Form 4 for TNDM TANDEM DIABETES CARE INC
Accepted 2021-10-14 00:00:00 ET · period of report 2021-10-13 · accession 0001438133-21-000186 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-14 | 2021-10-13 | TNDM | Morrison Susan | EVP, Chief Admin. Off | S - Sale+OE | $132.01 | -10.0K | 8,082 | -55% | -$1.33M |
| DM | 2021-10-14 | 2021-10-13 | TNDM | Morrison Susan | EVP, Chief Admin. Off | M - OptEx | $9.85 | +10.0K | 18.1K | +124% | +$99.0K |
| DM | 2021-10-14 | 2021-10-13 | TNDM | Morrison Susan | EVP, Chief Admin. Off | M - OptEx | $9.85 | +10.0K | 0 | New | +$99.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-13 | S | D | 10,048 | $132.01 | 8,082 | D | — | — | (F3) The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $132.00 to $132.70. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. |
| 2 | Common | Common Stock | 2021-10-13 | M | A | 4,145 | $11.06 | 12,227 | D | — | — | |
| 3 | Common | Common Stock | 2021-10-13 | M | A | 5,903 | $9.00 | 18,130 | D | — | — | |
| 4 | Derivative | Common Stock | 2021-10-13 | M | A | 4,145 | $11.06 | 0 | D | $11.06 · — to — | 4,145 Common Stock | (F4) The option vested as to twenty-five percent (25%) of the underlying shares on 04/23/2014, and the remaining shares vested in thirty-six (36) equal monthly installments thereafter. (F5) The expiration date for these options is 10 years from the date of grant. |
| 5 | Derivative | Common Stock | 2021-10-13 | M | A | 5,903 | $9.00 | 0 | D | $9.00 · — to — | 5,903 Common Stock | (F6) The options vested as to twenty-five percent (25%) of the underlying shares on 5/17/2018, and the remaining shares vested in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). (F5) The expiration date for these options is 10 years from the date of grant. |